Financial reports
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
ARS
2022 FY
Annual report to shareholders
27 Jul 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K/A
2022 FY
Annual report (amended)
27 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
22 Mar 24
8-K
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7 Mar 24
8-K
Other Events
15 Feb 24
8-K
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
6 Feb 24
8-K
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
9 Nov 23
8-K
Departure of Directors or Certain Officers
7 Sep 23
8-K
LINEAGE CELL THERAPEUTICS REPORTs SECOND QUARTER 2023 FINANCIAL
10 Aug 23
8-K
Other Events
21 Jun 23
8-K
Other Events
18 May 23
8-K
LINEAGE CELL THERAPEUTICS REPORTs FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
11 May 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
22 Mar 24
S-3
Shelf registration
7 Mar 24
424B5
Prospectus supplement for primary offering
6 Feb 24
424B5
Prospectus supplement for primary offering
6 Feb 24
S-8
Registration of securities for employees
13 Nov 23
424B5
Prospectus supplement for primary offering
18 May 23
424B5
Prospectus supplement for primary offering
21 Dec 21
S-8
Registration of securities for employees
28 Sep 21
S-3
Shelf registration
11 Mar 21
S-8
Registration of securities for employees
11 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
27 Jul 23
DEF 14A
Definitive proxy
27 Jul 23
PRE 14A
Preliminary proxy
11 Jul 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
2 Sep 21
DEFA14A
Additional proxy soliciting materials
3 Aug 21
DEF 14A
Definitive proxy
3 Aug 21
DEF 14A
Definitive proxy
10 Aug 20
DEFA14A
Additional proxy soliciting materials
10 Aug 20
Other
EFFECT
Notice of effectiveness
22 Mar 21
EFFECT
Notice of effectiveness
22 Mar 21
CORRESP
Correspondence with SEC
17 Mar 21
CORRESP
Correspondence with SEC
17 Mar 21
UPLOAD
Letter from SEC
16 Mar 21
UPLOAD
Letter from SEC
16 Mar 21
EFFECT
Notice of effectiveness
11 May 20
UPLOAD
Letter from SEC
6 May 20
CORRESP
Correspondence with SEC
6 May 20
CT ORDER
Confidential treatment order
14 Dec 17
Ownership